BDX - Mergers and acquisitions

Expands BD's portfolio of smart connected care solutions with leading monitoring technologies, including advanced AI-enabled clinical decision toolsCombination of leading monitoring and infusion platforms enables future innovation opportunities for closed–loop monitoring and treatment, integrating combined company data sets and interoperability capabilitiesBusiness renamed as BD Advanced Patient Monitoring, will be based in Irvine, Calif. and become part of BD Medical segmentKatie Szyman will continue to lead BD Advanced Patient Monitoring as worldwide presidentFRANKLIN LAKES, N.J., Sept. 3, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technolo

Acquisition adds to company's recent growth in high-technology pharmacy solutions and further accelerates the company's commitment to Smart, Connected Care – offering a customizable platform to optimize IV workflow FRANKLIN LAKES, N.J., July 28, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today it has acquired MedKeeper, a provider of modern, cloud-based pharmacy management applications. MedKeeper strategically complements BD's existing presence in the pharmacy – where the company has pioneered solu

- BD enters growing pharmacy automation market segment by offering a comprehensive set of technologies across the care continuum - Addition of Parata aligns with two key tenets of BD's innovation strategy: driving smart, connected care and enabling new care settings FRANKLIN LAKES, N.J., July 18, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX) today announced it has completed the acquisition of Parata Systems. Parata advances BD's transformative solutions strategy by providing a portfolio of innovative pharmacy automation solutions that power a growing netwo

FRANKLIN LAKES, N.J., Feb. 1, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced it has completed the acquisition of Cytognos, a privately held company headquartered in Salamanca, Spain, specializing in flow cytometry solutions for blood cancer diagnosis, minimal residual disease (MRD) detection and immune monitoring research for blood diseases.  The acquisition of Cytognos accelerates BD's strategy to support chronic disease management by expanding its portfolio of blood cancer diagnostics, immune a

FRANKLIN LAKES, N.J., Dec. 21, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced it has completed the acquisition of privately held Scanwell Health Inc., a leader in smartphone-enabled at-home medical tests. BD collaborated with Scanwell to develop the app used with the recently launched BD Veritor™ At-Home COVID-19 Test, the first at-home COVID-19 test that uniquely uses a smartphone camera and app to capture and interpret results, eliminating the human subjectivity in other visually read at-home

FRANKLIN LAKES, N.J., Dec. 9, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today it has acquired Tissuemed, Ltd., a privately held firm headquartered in Leeds, England that is an industry leader in developing self-adhesive surgical sealant films. The acquisition of Tissuemed, Ltd. expands BD's global offerings for surgeons outside of the United States. Tissuemed's lead product, Tissuepatch™, is a proprietary sealant technology that bonds to tissue to help control internal bleeding or prevent leaks f

FRANKLIN LAKES, N.J., Dec. 2, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today it has acquired Venclose, Inc., a provider of solutions for the treatment of chronic venous insufficiency (CVI) — a disease that is the result of malfunctioning valves and can lead to varicose veins. CVI represents a significant and growing therapeutic need within the health care system — impacting up to 40% of women and 17% of men in the United States.1 Venclose is a leader in CVI treatment through its innovative Radio

FRANKLIN LAKES, N.J., July 27, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today it has acquired Tepha, Inc., a leading developer and manufacturer of a proprietary resorbable polymer technology. Tepha's proprietary resorbable polymer (Poly 4-hydroxybutyric acid, P4HB) technology platform provides additional innovation potential that can accelerate the growth of BD's surgical mesh portfolio and drives the company into potential new areas within soft tissue repair, reconstruction and regeneration. Th

New subsidiary Veris acquires privately held oncology digital health company Oncodisc Inc. Technologies include first intelligent implantable vascular access port with biologic sensors and wireless communication combined with remote oncology digital healthcare platform NEW YORK, June 02, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (NASDAQ:PAVM, PAVMZ))) (the "Company" or "PAVmed"), a highly differentiated, multi-product, commercial-stage medical technology company, today announced the launch of a new subsidiary, digital health company Veris Health Inc. ("Veris"), which acquired Oncodisc Inc. ("Oncodisc"), a digital health company with groundbreaking tools to improve personalized ca

FRANKLIN LAKES, N.J., March 4, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired GSL Solutions, Inc. ("GSL"), a privately-held company that develops smart medication devices for the storage and tracking of controlled substances and patient specific medications that improve the security, efficiency and compliance of medication storage, as well as analytic capabilities to further improve inventory management, including of controlled substances, regulatory compliance and patient safety.  This acquisition expands BD's advanced medication management capabilities to further meet the needs of retail pha